Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury

Journal of Clinical Investigation

Volumn 110, Issue 11, 2002, Pages 1703-1716

  Belperio, John A ^a   Keane, Michael P ^a   Burdick, Marie D ^a   Londhe, Vedang ^a   Xue, Ying Ying ^a   Li, Kewang ^a   Phillips, Roderick J ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE RECEPTOR CXCR2; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HEMODYNAMIC MONITORING; LUNG INJURY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VENTILATOR;

EID: 0036894541     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215849     Document Type: Article

References (81)

1. Ware, L.B., and Matthay, M.A. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342:1334-1349.
2. Ranieri, V.M., et al. 1999. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA. 282:54-61.
3. Kollef, M.H., and Schuster, D.P. 1995. The acute respiratory distress syndrome. N. Engl. J. Med. 332:27-37.
4. Dreyfuss, D., Soler, P., Basset, G., and Saumon, G. 1988. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am. Rev. Respir. Dis. 137:1159-1164.
5. Corbridge, T.C., et al. 1990. Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am. Rev. Respir. Dis. 142:311-315.
6. 2000. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med. 342:1301-1308.
7. Webb, H.H., and Tierney, D.F. 1974. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end-expiratory pressure. Am. Rev. Respir. Dis. 110:556-565.
8. Dreyfuss, D., and Saumon, G. 1998. Ventilator-induced lung injury: Lessons from experimental studies. Am. J. Respir. Crit. Care Med. 157:294-323.
9. Bozic, C.R., et al. 1994. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J. Biol. Chem. 269:29355-29358.
10. Lee, J., et al. 1995. Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155:2158-2164.
11. Cerretti, D.P., et al. 1993. The murine homologue of the human interleukin-8 receptor type B maps near the Ity-Lsh-Bcg disease resistance locus. Genomics. 18:410-413.
12. Harada, A., et al. 1994. Cloning of a CDNA encoding a mouse homolog of the interleukin-8 receptor. Gene. 142:297-300.
13. Villard, J., et al. 1995. GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 152:1549-1554.
14. Goodman, R.B., et al. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154:602-611.
15. Aggarwal, A., Baker, C.S., Evans, T.W., and Haslam, P.L. 2000. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur. Respir. J. 15:895-901.
16. Kurdowska, A., et al. 2001. Anti-interleukin 8 autoantibody: Interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. Am. J. Respir. Crit. Care Med. 163:463-468.
17. Miller, E.J., et al. 1992. Elevated levels of NAP-1/interleukin -8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427-432.
18. Donnelly, S.C., et al. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 341;643-647.
19. Chollet-Martin, S., et al. 1993. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect. Immun. 61:4553-4559.
20. Meduri, G.U., et al. 1995. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 108:1303-1314.
21. Mehrad, B., et al. 1999. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol. 163:6086-6094.
22. Moore, T.A., et al. 2000. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J. Immunol. 164:908-915.
23. Tsai, W.C., et al. 2000. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 68:4289-4296.
24. Greenberger, M.J., et al. 1996. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173:159-165.
25. Huffnagle, G.B., et al. 1995. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155:4790-4797.
26. Huffnagle, G.B., et al. 1997. Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159:318-327.
27. Keane, M.P., et al. 1999. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162:5511-5518.
28. Belperio, J.A., et al. 2000. The role of the CC chemokine, RANTES, in acute lung allograft rejection. J. Immunol. 165:461-472.
29. Olszyna, D.P., et al. 2001. CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection. J. Infect. Dis. 184:301-307.
30. Imanaka, H., et al. 2001. Ventilator-induced lung injury is associated with neutrophil infiltration, macrophage activation, and TGF-beta 1 mRNA upregulation in rat lungs. Anesth. Analg. 92:428-436.
31. Kawano, T., et al. 1987. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J. Appl. Physiol. 62:27-33.
32. Colletti, L.M., et al. 1995. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J. Clin. Invest. 95:134-141.
33. Nishina, K., et al. 1998. Intravenous lidocaine attenuates acute lung injury induced by hydrochloric acid aspiration in rabbits. Anesthesiology. 88:1300-1309.
34. Green, T.P., Johnson, D.E., Marchessault, R.P., and Gatto, C.W. 1988. Transvascular flux and tissue accrual of Evans blue: Effects of endotoxin and histamine. J. Lab. Clin. Med. 111:173-183.
35. Saria, A., and Lundberg, J.M. 1983. Evans blue fluorescence: Quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Methods. 8:41-49.
36. Chumakov, K.M. 1994. Reverse transcriptase can inhibit PCR and stimulate primer-dimer formation. PCR Methods Appl. 4:62-64.
37. Belperio, J.A., et al. 2001. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J. Clin. Invest. 108:547-556. doi:10.1172/JCI200112214.
38. Belperio, J.A., et al. 2002. Critical role for CXCR3 chemokine biology in the pathogenesis of Bronchiolitis obliterans syndrome. J. Immunol. 169:1037-1049.
39. Lee, W.L., and Downey, G.P. 2001. Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care. 7:1-7.
40. Rinaldo, J.E. 1986. Mediation of ARDS by leukocytes. Clinical evidence and implications for therapy. Chest. 89:590-593.
41. Steinberg, K.P., et al. 1994. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir Crit. Care Med. 150:113-122.
42. Folz, R.J., Abushamaa, A.M., and Suliman, H.B. 1999. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J. Clin. Invest. 103:1055-1066.
43. Kawabata, K., et al. 2000. Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am. J. Respir Crit. Care Med. 161:2013-2018.
44. Thommasen, H.V., Russell, J.A., Boyko, W.J., and Hogg, J.C. 1984. Transient leucopenia associated with adult respiratory distress syndrome. Lancet. 1:809-812.
45. Shattuck-Brandt, R.L., and Richmond, A. 1997. Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. CancerRes. 57:3032-3039.
46. Devalaraja, M.N., Wang, D.Z., Ballard, D.W., and Richmond, A. 1999. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylacion in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription. Cancer Res. 59:1372-1377.
47. Yang, J., and Richmond, A. 2001. Constitutive IkappaB kinase activity, correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res. 61:4901-4909.
48. Weiland, J.E., et al. 1986. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am. Rev. Respir. Dis. 133:218-225.
49. Martin, T.R., Pistorese, B.P., Hudson, L.D., and Maunder, R.J. 1991. The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections. Am. Rev. Respir. Dis. 144:254-262.
50. Mead, J., Takishima, T., and Leith, D. 1970. Stress distribution in lungs: A model of pulmonary elasticity. J. Appl. Physiol. 28:596-608.
51. Hickling, K.G., Henderson, S.J., and Jackson, R. 1990. Low mortality associated with Iow volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med. 16:372-377.
52. Amato, M.B., et al. 1995. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am. J. Respir. Crit. Care Med. 152:1835-1846.
53. Amato, M.B., et al. 1998. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl. J. Med. 338:347-354.
54. Dreyfuss, D., Basset, G., Soler, P., and Saumon, G. 1985. Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am. Rev. Respir. Dis. 132:880-884.
55. de Durante, G., et al. 2002. ARDSNet lower tidal volume ventilatory strategy may generate intrinsic positive end-expiratory pressure in patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 165:1271-1274.
56. Volgyesi, G.A., Tremblay, L.N., Webster, P., Zamel, N., and Slutsky, A.S. 2000. A new ventilator for monitoring lung mechanics in small animals. J. Appl. Physiol. 89:413-421.
57. Kolobow, T., et al. 1987. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am. Rev Respir. Dis. 135:312-315.
58. Frank, J.A., et al. 2002. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am. J. Respir. Crit. Care Med. 165:242-249.
59. Tremblay, L., Valenza, F., Ribeiro, S.P., Li, J., and Slutsky, A.S. 1997. Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model. J. Clin. Invest. 99:944-952.
60. Pugin, J., et al. 1998. Activation of human macrophages by mechanical ventilation in vitro. Am. J. Physiol. 275:L1040-L1050.
61. Vlahakis, N.E., Schroeder, M.A., Limper, A.H., and Hubmayr, R.D. 1999. Stretch induces cytokine release by alveolar epithelial cells in vitro. Am. J. Physiol. 277:L167-L173.
62. Mourgeon, E., et al. 2000. Mechanical stretch stimulates macrophage inflammatory protein-2 secretion from fetal rat lung cell. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L699-L706.
63. Blackwell, T.S., and Christman, J.W. 1997. The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17:3-9.
64. Beg, A.A., et al. 1992. 1 kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: A mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
65. Beg, A.A., Finco, T.S., Nanterrnet, P.V., and Baldwin, A.S.,Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation. Mol. Cell. Biol. 13:3301-3310.
66. Baldwin, A.S., Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14:649-683.
67. Maniatis, T. 1997. Catalysis by a multiprotein IkappaB kinase complex. Science. 278:818-819.
68. Rodriguez, M.S., Michalopoulos, I., Arenzana-Seisdedos, F., and Hay, R.T. 1995. Inducible degradation of I kappa B alpha in vitro and in vivo requires the acidic C-terminal domain of the protein. Mol. Cell. Biol. 15:2413-2419.
69. Lentsch, A.B., Czermak, B.J., Bless, N.M., Van Rooijen, N., and Ward, P.A. 1999. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Am. J. Respir. Cell Mol. Biol. 20:692-698.
70. Held, H.D., Boettcher, S., Hamann, L., and Uhlig, S. 2001. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids. Am. J. Respir. Crit. Care Med. 163:711-716.
71. Metinko, A.P., Kunkel, S.L., Standiford, T.J., and Strieter, R.M. 1992. Anoxia-hyperoxia induces monocyte-derived interleukin-8. J. Clin. Invest. 90:791-798.
72. Katakurum, M., et al. 1994. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93:1564-1570.
73. Auten, R.L., et al. 2001. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. J. Pharmacol. Exp. Ther. 299:90-95.
74. Schimmer, R.C., et al. 1997. Streptococcal cell wall-induced arthritis. Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. J. Immunol. 159:4103-4108.
75. Kulke, R., et al. 1998. The CXC receptor 2 is overexpressed in psoriatic epidermis. J. Invest Dermatol. 110:90-94.
76. Nirodi, C.S., et al. 2000. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen. 8:371-382.
77. Williams, E.J., et al. 2000. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J. Pathol. 192:533-539.
78. Addison, C.L., et al. 2000. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J. Immunol. 165:5269-5277.
79. Keane, M.P., et al. 2001. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 164:2239-2242.
80. Ben-Baruch, A., Michiel, D.F., and Oppenheim, J.J. 1995. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 270:11703-11706.
81. Goodman, D.J., Von Albertini, M., Willson, A., Millan, M.T., and Bach, F.H. 1996. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation. 61:763-771.